Key result
Astemizole (2 μM) increased Ca2+ deposition evoked by classical or pathological induction pathways in SaOS-2 and MG-63 osteosarcoma cell cultures without causing cytotoxicity.
Why the study?
Based on the role of ion channels in osteogenesis and ectopic hEag1 expression in osteosarcoma, the study evaluated whether pharmacological modulation of hEag1 affects osteogenic differentiation.
Does astemizole increase Ca2+ deposition in osteosarcoma cell cultures?
Does astemizole increase Ca2+ deposition in osteosarcoma cell cultures?
Inhibition of hEag1 by astemizole enhances osteogenic stimuli-induced mineral matrix formation in osteosarcoma cell lines, suggesting a potential approach to drive terminal differentiation.
Answers are grounded in this paper and cite their sources.
In vitro osteosarcoma findings are hypothesis-generating for hEag1 inhibition; should not change practice without in vivo validation.
The hEag1 (Kv10.1) K+ channel is normally found in the brain, but it is ectopically expressed in tumor cells, including osteosarcoma. Based on the pivotal role of ion channels in osteogenesis, we tested whether pharmacological modulation of hEag1 may affect osteogenic differentiation of osteosarcoma cell lines. Using molecular biology (RT-PCR), electrophysiology (patch-clamp) and pharmacology (astemizole sensitivity, IC50 = 0.135 μM) we demonstrated that SaOS-2 osteosarcoma cells also express hEag1 channels. SaOS-2 cells also express to KCa1.1 K+ channels as shown by mRNA expression and paxilline sensitivity of the current. The inhibition of hEag1 (2 μM astemizole) or KCa1.1 (1 mM TEA) alone did not induce Ca2+ deposition in SaOS-2 cultures, however, these inhibitors, at identical concentrations, increased Ca2+ deposition evoked by the classical or pathological (inorganic phosphate, Pi) induction pathway without causing cytotoxicity, as reported by three completer assays (LDH release, MTT assay and SRB protein assay). We observed a similar effect of astemizole on Ca2+ deposition in MG-63 osteosarcoma cultures as well. We propose that the increase in the osteogenic stimuli-induced mineral matrix formation of osteosarcoma cell lines by inhibiting hEag1 may be a useful tool to drive terminal differentiation of osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Mészáros et al. (2022) studied Osteosarcoma. Astemizole was evaluated on Ca2+ deposition. Astemizole (2 μM) increased Ca2+ deposition evoked by classical or pathological induction pathways in SaOS-2 and MG-63 osteosarcoma cell cultures without causing cytotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: